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Background: HyperBaric Oxygen (HBO) therapy involves exposure to pure oxygen in a pressurized room, and it
is an already well-established treatment for various conditions, including those originated by serious infections.
Starting from the observation of an increased number of patients who were accessing our HBO units for diseases
supported from concomitant multidrug-resistant microorganisms, as well as considering the evident clinical benefit
and laboratory final outcome of those patients at the end of the treatment, aim of our study was to measure,
or better define at least, if there was any interaction between a hyperbaric environment and some selected
microorganisms and if those positive results were due to the increased oxygen partial pressure (pO2) value or just
to the increased pressure, regardless of the fraction of inspired oxygen (FiO2) applied (21100%).
Design and methods: We applied various increased pO2 values in a hyperbaric environment. Our study design
was tailored in four steps to answer four specific questions, ordered in a progressive process: OxyBioTest (OBT)-1,2,3,
and 4. Specifically, we chose to investigate possible changes in the Minimum Inhibitory Concentration (MIC) and
in the Minimum Bactericidal Concentration (MBC) of multi-resistant microorganisms after a single session of
hyperbaric therapy.
Results: OBT-1 and OBT-2 provide a semi-quantitative confirmation of the bacterio-cidal and cytostatic effects
of HBO. HBO is cidal only if the total exposure pressure is elevated, and cidal or cytostatic effect are not always
dependent on the pO2 applied.
OBT-4 has shown the adjuvant effect of HBO and antimicrobial drug against some selected bacteria.
Discussion: We seem allowed to hypothesize that only in case of a good approach to a lesion, permitting smaller
bacterial loads thanks to surgical debridement and/or eventual antibiotic therapy for example, You can observe
the clear effectiveness of the HyperBaric Oxygen (HBO) exposure as a valid adjuvant therapy, even when that lesion
is substained from multidrug-resistant micro-organisms. On the contrary when the bacterial load is very high we
observe an unchanged situation or a just a slightly diminishing in the number of cfu/ml.
Conclusions: Even if confined in this ‘in vitro’ environment and in a single treatment, just knowing the
microorganism strain responsible of the lesion we seem allowed to both weight the possible related effectiveness
using HBO Therapy (HBOT) and derive the best pO2 to treat the case. A further possible development of the study
highlights a comparison between Acinetobacter baumannii (ACBA) and Pseudomonas aeruginosa (PSAE), and
Escherichia coli (ESCO) and Klebsiella pneumoniae (KLPN).
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Table 1 Experiment nr. 1-2: Micro-organisms under
hyperbaric test
ATCC 29213 STaphylococcus AUreus Gram-positive facultative
Zanon et al. Medical Gas Research 2012, 2:24 Page 2 of 9
http://www.medicalgasresearch.com/content/2/1/24Background
We named OxyBioTest (OBT) the present study to bet-
ter evoke what we were testing: the eventual natural anti-
biotic capabilities, if any, of either Hyperbaric Oxygen
(FiO2 100% under hyperbaric condition) or just pressure
itself [normoxic environment (FiO2 21%) under hyper-
baric condition].
Materials and methods
In this study we applied a tailored protocol named OxyBio-
Test (OBT), investigating potential that hyperbaric oxygen,
and/or just pressure itself, could have as natural antibiotic.
The different phases of the study were aimed to evalu-
ate different pressures [1.0, 2.5 and 2.8 ATA; respectively
equal to a normobaric environment, and to 15 and
18 meters of water column (msw) or 147.09176.50 kPa]
and different FiO2 (0.211), applied in various combina-
tions upon selected microorganisms. We considered CFU/
ml values (colony forming units/ml) and specific stress
indexes, as impaired growth or capsule variations.
Upon reviewing the literature [1-6], the aim of the
study was to define the application of various increased
pO2 values, and to determine any interaction between a
hyperbaric environment and selected microorganisms.
The study design was tailored in four steps to reply to
four specific questions, ordered in a progressive process:
OBT-1: a semi-quantitative study of the bacterial
replication under hyperbaric conditions after their
exposure to 21% and 100% O2 (the test has been
performed at a 2.52.8 ATA bathymetry and with a
manual final plating, during the pure microbiology-lab
phase of the test) [7].
OBT-2: same sequence as in OBT-1, but automated
final plating to standardize and verify the human
variable of the previous procedure [8].
OBT-3: a transition test designed for the experimental
material and methods to adopt in the following test
(OBT-4), presented as more challenging.
OBT-4: upon positive findings at our first and/or second
test, to quantify the adjuvant effect, if any, of HBO and
antimicrobic against some selected bacteria.(STAU) anaerobic bacteria








ATCC 29212 ENterococcus FAecalis Gram-positive facultative OBT-1: In our first experiment we used 5 different
microorganism strains [4 American Type Culture
Collection (ATCC) strains and 1 multi-sensitive
strain isolated from a patient], for 3 three different




bacteriaa) obligate aerobic (requires oxygen as a source of
energy and therefore for growth),b) anaerobic (derives energy from fermentative
processes in the absence of oxygen, it is found in
necrotic or abscessed tissues), and
c) facultative anaerobic (derives energy from aerobic
or anaerobic metabolism, it includes most of the
intestinal pathogens) (Table 1).
We proceeded as follows [9]:
Step 1: the material
– Selection of the bacterial strains:
ATCC (American Type Culture Collection) 29213
or STAU, ATCC 25922 or ESCO, ATCC 27853 or
PSAE, ATCC 29212 or ENFA, and Bacteroides
Fragilis (BAFR) from a patient.
– Incubation, at 37°C for 24 hours, of a 2 ml tryptose
broth suspensions prepared from these strains and
used for the experiment the following day.
– The following day, starting from these bacterial
suspensions, we prepared for each group a three
step 1:100 serial saline dilution (1998 μl of 0.45%
NaCl and 2 μl of bacterial suspension).
Step 2: hyperbaric/normobaric exposure
Four groups of experiments were completed
(A1, A2, B, C):
– A1 group: exposure to 100%O2 at 2.8 ATA
(18 msw; 176.50 kPa) for 75 minutes,
– A2 group: exposure to 100%O2 at 2.5 ATA
(15 msw; 147.09 kPa) for 75 minutes,
– B group: exposure to 21%O2 at 2.8 ATA
(18 msw; 176.50 kPa) for 75 minutes,
– C group (control): exposure to 21%O2 at
1.0 ATA (0 m) for 75 minutes.
In order to limit the bacterial growth, ice packs were
applied to the suspensions during their 10 minute
transfer (Laboratory/Hyperbaric-Chamber).
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– STAU, ESCO, PSAE, ENFA strains
At the end of the exposure to the hyperbaric
environment, or to the normobaric conditions,
the 3 diluted suspensions for each of the 4 four
experimental groups (12 per group, for a total
of 48 tubes) were manually streaked on chocolate-
agar plates and incubated for 24 hours at 37°C.
– BAFR strain
At the end of the exposure to the hyperbaric
environment, or to the normobaric conditions,
the 3 diluted suspensions for each of the 4 four
experimental groups (12 tubes) were immediately
streaked on blood-agar plates and incubated
under anaerobic conditions for 24 hours
at 37°C.
Step 4: observation of the bacterial growth
 OBT-2: It differs from OBT-1 for the sole step-3,
where we verified the weight of the human variable
of the procedure via a Walk Away Specimen
Processing workstation.
Step 1: see OBT-1. Step 2: see OBT-1.
Step 3: plating and incubation (60 plates)
– STAU, ESCO, PSAE, ENFA strains
At the end of the exposure to the hyperbaric
environment or to the normobaric conditions,
the 3 diluted suspensions for each of the
4 four experimental groups (12 per group,
for a total of 48 tubes) were streaked on
chocolate-agar plates and then incubated
for 24 hours at 37°C.
– BAFR strain.
At the end of the exposure to the hyperbaric
environment or to the normobaric conditions,
the 3 diluted suspensions for each of the four
experimental groups (12 tubes) were immediately
streaked on blood-agar plates and incubated
under anaerobic conditions for 24 hours at 37°C.
– In OBT-2, to test the human-operator variable
of our previous test, the planting procedure was
WASP-assisted, via a Walk Away Specimen
Processing workstation that granted the
automated pre-analytical plating.
Step 4: see OBT-1.
 OBT-3 : OxyBioTest (OBT)-3 has been used just a
warm-up test for the experiment protocol to be used in
OBT-4. In OBT-3 we have also tried to evaluate theinteraction of oxygen-antibiotic with other methods,
such as the Kirby Bauer and the ‘E-Test’.
 OBT-4 : The actual final phase of the study.
Some descriptive notes on the multi-resistant
microorganisms we used in this case:
Acinetobacter baumannii (ACBA) - a nonmotile rod,
more specifically an obligate aerobic nonfermentative
gram-negative pleomorphic bacillus.
Usually found in soil and water, it can survive in
soaps and disinfectants. It is found also in
humans, and is unknown if it exists as a
contaminant or commensal [skin (incidence: up
to 25%) and vagina (incidence: 5-15%)].
Acinetobacter family is usually characterized by
multi-resistance, especially in strains responsible
for nosocomial infections. They can behave as
opportunistic pathogens, particularly in burns,
debilitated patients, and immunosuppressed
patients. It can also cause meningitis, septicemia,
endocarditis, soft tissue infections, urinary tract
infections and pneumonia.
Klebsiella pneumoniae (KLPN) - capsulated
gram-negative facultative anaerobic microorganism.
KLPN can be found in the human gastrointestinal
tract, skin and nasopharynx. Nevertheless, KLPN
may also be found in the environment (water, soil,
sewage). The KLPN frequently causes nosocomial
infections (urinary tract infections, pneumonia,
septicemia, soft tissue infections) which can be
fatal in immunocompromised patients.
We chose these two different microorganisms aware
that they differ in two fundamental aspects:
ACBA is an obligate aerobic organism while KLPN
is a facultative anaerobe;
ACBA is a multi-resistant organism while KLPN
acquires mechanisms of drug resistance in relation
to the selective pressure of antibiotics administered
in hospital. Moreover KLPN is inherently equipped
with a capsule whose level of ‘comfort’ or ‘stress’ (in
possible future electronic microscope studies) could
better depict its progress on the way of a firm
multidrug resistance.
Step 1 : Selection of multiresistant bacterial strains
from two hospitalized patient samples:
a. Klebsiella pneumoniae (KLPN) identity number






















Zanon et al. Medical Gas Research 2012, 2:24 Page 4 of 9
http://www.medicalgasresearch.com/content/2/1/24b. Acinetobacter baumannii (ACBA) identity
number 8000939446 (material: skin swab).
Step 2: Analysis of the two bacterial strain specific
antibiotic sensitivity (Table 2).
Step 3: Isolation of the two strains in agar-chocolate
and subsequent preparation of two bacterial
suspensions to be incubated for 24 hours at 37°C.
Step 4: Preparation of 4 MIC (Minimum Inhibitory
Concentration) panels for Gram-negative bacilli for
each of the two strains (SensititreW by TREK
Diagnostic Systems; see the picture below) and an
immediate hyperbaric treatment as follows:
Four groups (A1, A2, B, C):
– A1 group (2 MICs): exposure to 100%O2 at 2.8
ATA (18 msw; 176.50 kPa) for 75 minutes,
– A2 group (2 MICs): exposure to 100%O2 at 2.5
ATA (15 msw; 147.09 kPa) for 75 minutes,
– B group (2 MICs): exposure to 21%O2 at 2.8 ATA
(18 msw; 176.50 kPa) for 75 minutes,
– C group (control) (2 MICs): exposure to 21%O2
at 1.0 ATA (0 msw) for 75 minutes.e 2 Experiment nr. 4: Antibiotic sensitivity analysis
icrobial KLPN ACBA
MIC READING MIC READING
cillin ≥ 32 resistant ≥ 32 resistant
icillin/
lanic acid
≥ 32 resistant ≥ 32 resistant








xime 16 resistant ≥ 64 resistant
idime ≥ 64 resistant ≥ 64 resistant
ime 8 resistant ≥ 64 resistant
nem ≥ 16 resistant ≥ 16 resistant
enem 4 resistant ≥ 16 resistant
cin 8 sensitive ≥ 64 resistant
micin ≥ 16 resistant ≥ 16 resistant
loxacin ≥ 8 resistant ≥ 8 resistant






urantoin ≥512 resistant ≥
512
resistant
m ≥320 resistant ≥
320
resistant
in 1 sensitiveIn order to limit the bacterial growth, ice packs
were applied to the suspensions during their
10 minute transfer from the Laboratory to the
Hyperbaric Chamber.
At the end of the exposure to the hyperbaric
environment or to the normobaric conditions,
the 8 MIC panels were incubated at 37°C for
24 hours.
Step 5: MIC panel readings followed by agar-
chocolate plating of the content of the broth in the
microwells where then bacterial growth was
inhibited (in order to determine the MBC) and plate
incubation for 24 hours at 37°C.
Step 6: MBC (Minimum Bactericidal Concentration)
identification.Results
– OBT-1 and OBT-2
Showed similar results (Table 3).
OBT-2 confirmed our experimental findings at
the end of OBT-1 test, showing results more
congruent with the specific characteristic of
each group of bacteria.
– OBT-3
Confirmed to be just a transition test to perfect
the method to apply in the last phase (OBT-4).
The broth suspension in the microwells of
our MICs has proved to be more effective as
compared to the KB and E-Test. MIC plate allows
to simultaneously test multiple antibimicrobial
molecules, and is not affected by the human
variable (KB-Test requires a lot of experience
to run it properly; one thing is to talk about
minimal differences between manual and
automated WASP-plating procedures in a
well-trained team, but quite different to think
about the KB-test in the same way).
– OBT-4
After the semi-quantitative confirmation of the
cidal and cytostatic effects of HBO (OBT1 and
OBT2), we continued to investigate if there
were possible adjuvant interactions between
antimicrobial conventional therapy and HBOT.
Specifically, we chose to investigate possible changes
in the MIC (Minimum Inhibitory Concentration)
and in the MBC (Minimum Bactericidal
Concentration) of multiresistant micro-organisms
after a single session of hyperbaric therapy
[Figures 1, 2, 3, 4, 5, 6, 7].
Table 3 Bacteria growth after exposure to Oxygen and/or Pressure
STAU 29213 - facultative anaerobic Dilution 1 Dilution 2 Dilution 3
A1 group [100% O2 at 2.8 ATA (18 msw; 176.50 kPa)] 10^6 cfu/ml 10^3 cfu/ml No growth
A2 group [100% O2 at 2.5 ATA (15 msw; 147.09 kPa)] 10^6 cfu/ml 10^3 cfu/ml No growth
B group [21% O2 at 2.8 ATA (18 msw; 176.50 kPa)] 10^6 cfu/ml 10^3 cfu/ml No growth
C group [21% O2 at 1.0 ATA (0 msw)] 10^6 cfu/ml 10^3 cfu/ml No growth
ESCO 25922 - facultative anaerobic Dilution 1 Dilution 2 Dilution 3
A1 group [100% O2 at 2.8 ATA (18 msw; 176.50 kPa)] 10^6 cfu/ml 10^5 cfu/ml No growth
A2 group [100% O2 at 2.5 ATA (15 msw; 147.09 kPa)] 10^6 cfu/ml 10^3 ufc/ml No growth
B group [21% O2 at 2.8 ATA (18 msw; 176.50 kPa)] 10^6 cfu/ml 10^5 cfu/ml 10^3 ufc/ml
C group [21% O2 at 1.0 ATA (0 msw)] 10^6 cfu/ml 10^3 cfu/ml No growth
PSAE 27853 - obligate aerobic Dilution 1 Dilution 2 Dilution 3
A1 group [100% O2 at 2.8 ATA (18 msw; 176.50 kPa)] 10^6 cfu/ml 10^5 cfu/ml 10^4 ufc/ml
A2 group [100% O2 at 2.5 ATA (15 msw; 147.09 kPa)] 10^6 cfu/ml 10^5 cfu/ml 10^3 ufc/ml
B group [21% O2 at 2.8 ATA (18 msw; 176.50 kPa)] 10^6 cfu/ml 10^5 cfu/ml 10^3 ufc/ml
C group [21% O2 at 1.0 ATA (0 msw)] 10^6 cfu/ml 10^4 cfu/ml 10^3 ufc/ml
ENFA 29212 - facultative anaerobic Dilution 1 Dilution 2 Dilution 3
A1 group [100% O2 at 2.8 ATA (18 msw; 176.50 kPa)] 10^6 cfu/ml 10^3 cfu/ml No growth
A2 group [100% O2 at 2.5 ATA (15 msw; 147.09 kPa)] 10^6 cfu/ml 10^3 cfu/ml No growth
B group [21% O2 at 2.8 ATA (18 msw; 176.50 kPa)] 10^6 cfu/ml 10^5 cfu/ml 10^3 ufc/ml
C group [21% O2 at 1.0 ATA (0 msw)] 10^6 cfu/ml 10^5 cfu/ml 10^3 ufc/ml
BAFR (from patient) - anaerobic Dilution 1 Dilution 2 Dilution 3
A1 group [100% O2 at 2.8 ATA (18 msw; 176.50 kPa)] 10^4 cfu/ml No growth No growth
A2 group [100% O2 at 2.5 ATA (15 msw; 147.09 kPa)] 10^5 cfu/ml 10^3 cfu/ml No growth
B group [21% O2 at 2.8 ATA (18 msw; 176.50 kPa)] 10^5 cfu/ml 10^3 cfu/ml No growth
C group [21% O2 at 1.0 ATA (0 msw)] 10^6 cfu/ml 10^4 cfu/ml 10^3 ufc/ml
Legend: cfu=Colony Forming Unit.
Figure 1 Klebsiella pneumoniae (KLPN) exposed to 100% O2 at 2.8 ATA.
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Figure 2 KLPN plate exposed to 21% O2 at 2.8 ATA.
Figu
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increasing number of patients accessing our




– When the bacterial load is very high (as in case in
which it is not possible to have a sufficient
debridment of the lesion) we observed an
unchanged situation or a just a slightly diminishing
in the number of cfu/ml.
– As the dilution gets a lower presence of bacteria
(2nd and 3rd dilutions; clinically corresponding to a
better approach to the lesion) the HyperBaricre 3 KLPN plate exposed to 21% O2 at 1.0 ATA.Oxygen (HBO) exposure can clearly show
its effectiveness.
Even if confined in this ‘in vitro’ environment, we
seem now allowed, just depending on the microorganism
strain responsible of the lesion, to decide if there’s indi-
cation or not to use HBO Therapy (HBOT), and which
could be the right pO2 to apply.
As a direct result of such an exposure to HBO:
– the obligate aerobic microorganism growth (PSAE)
is better as pressure and pO2 arise
– the facultative anaerobic bacteria, with a common
unchanged profile, show different specific behaviors:
STAU> generally speaking, it has no appreciable
changes as per growth and cfu/ml,
Figure 4 KLPN plate exposed to 100% O2 at 2.5 ATA.
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higher cfu/ml values at depth, not depending from pO2
applied (same at 21% and 100% O2 when at 2.8 ATA,
while there is a smaller cfu/ml value at 2.5 ATA),
ENFA> 2nd and 3rd dilutions show HBO exposure
effectiveness is more dependent on FiO2 applied than on
the mere pressure increase.
– anaerobic microorganism (as BAFR) gives
evidence of an impaired growth and cfu/ml value,
apparently directly related to the bathymetry
and FiO2 applied.
These results indicate that hyperbaric oxygen, gener-
ally speaking, is cidal only if the total exposure pressure
is elevated.
The automation we used could validate our previous
conclusion: the cidal and cytostatic effects of hyper-
baric oxygen are more evident as the pressure increases,Figure 5 Acinetobacter baumanii (ACBA) exposed to 100% O2 at 2.8and are not always depending on which O2 tension
is applied.Conclusions
The first experiment demonstrated that microorganisms
exposed to hyperbaric oxygen behave, in relation to
bacterial growth, according to their specific physical-
biochemical profile.
A cross-check of our results seems lacking in major
experimental errors, allowing to conclude HBO is cidal
only if the total exposure pressure is elevated, and cidal or
cytostatic effect are not always dependent on pO2 applied.
The human procedure used, compared to an auto-
mated plating system (WASP), showed a not significant
margin of error.
Comparing the MIC panels after 24 hours of incuba-
tion at 37°C, revealed a different behavior between
KLPN and ACBA.ATA.
Figure 6 ACBA plate exposed to 21% at 2.8 ATA.
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panel “C” (control group with normobaric oxygen at sur-
face) showed the expected resistance to antibiotics in it,
the MIC panel “A1” (the compression with 100% O2 at
18msw= 176.50kPa) highlighted an attenuation of drug
resistance since 4 different antibiotics (AXO, CHL, FOX,
TOB) were able to inhibit visible growth of the organism
even at concentrations lower than those found in the
panel “C” (low MIC). In “A2” and “B” panels (100% O2
at 15msw= 147.09kPa and 21% O2 at 18msw= 176.50
kPa) the MICs drug resistances, compared to control,
were not reduced while rather slightly wider.
As per ACBA, the MIC corresponding to the control
panel “C” (control group with normobaric oxygen at sur-
face) showed the expected resistance to antibiotics in it,
the MIC panel “A1” (the compression with 100% O2
at 18msw=176.50kPa) highlighted an increase in drug
resistance. We registered that 3 different antibiotics (A/S,
IMI, EFF) were able to inhibit visible growth of theFigure 7 ACBA plate exposed to 21% at 1.0 ATA.microorganism only at concentrations greater than
those detected in the panel “C” (increase in MIC), and
in the case of the antibiotic CHL bacterial growth was
visible in all the microwells in the panel. The panel
“A2” had an increased drug resistance compared with
control.
We cannot conclude whether the different behavior of
the two microorganisms is due to their different oxygen
metabolism (ACBA in this case would increase its
resistance as its metabolism is highly dependent on
oxygen and ACBA received different but higher pO2
exposures than control panel; on the contrary KLPN
behavior could probably show to be due to two mechan-
isms: indirectly stressed not having enough enzyme
resources to counteract the O2 free radicals, and at the
same time KLPN could perceive the more convenient
aerobic environment of the chamber as a stress-free
situation, lowering its guard (usually expressed as multi-
drug resistance).
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repeat the experiment introducing other microorganisms
to compare to ACBA (obligate aerobic microorganism)
and eventually another anaerobic as optional to compare
to KLPN. Therefore a possible development could see a
comparison between ACBA and PSAE, and eventually
ESCO and KLPN (the latter case would be interesting to
analyze a multi-sensitive KLPN strain).
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